Patents by Inventor Meagan P. O'Brien

Meagan P. O'Brien has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of treating allergy using anti-Bet v 1 antibodies
    Patent number: 11897945
    Abstract: The present disclosure provides methods for treating, preventing, or ameliorating one or more symptoms of birch allergy or allergic disease in a subject by administering to the subject an antibody or antigen-binding fragment thereof that binds Bet v 1, or a cocktail of antibodies or antigen-binding fragments thereof that bind Bet v 1.
    Type: Grant
    Filed: June 30, 2021
    Date of Patent: February 13, 2024
    Assignee: REGENERON PHARMACEUTICALS, INC.
    Inventors: Amanda Atanasio, Gary Herman, Meagan P. O'Brien, Jamie M. Orengo, Lorah Perlee
  • METHODS FOR TREATING ALLERGY AND ENHANCING ALLERGEN-SPECIFIC IMMUNOTHERAPY BY ADMINISTERING AN IL-4R ANTAGONIST
    Publication number: 20230293682
    Abstract: Methods for enhancing the efficacy, safety, and/or tolerability of a grass allergen-specific subcutaneous immunotherapy (SCIT) regimen in a subject having a grass allergy are provided. Methods comprising administering to a subject in need thereof a therapeutic composition comprising an interleukin-4 receptor (IL-4R) antagonist, such as an anti-IL-4R antibody or antigen-binding fragment thereof, are provided.
    Type: Application
    Filed: October 19, 2022
    Publication date: September 21, 2023
    Inventors: Jennifer D. HAMILTON, Meagan P. O'BRIEN, Allen RADIN, Marcella RUDDY, Heribert STAUDINGER
  • Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an IL-4R antagonist
    Patent number: 11504426
    Abstract: Methods for enhancing the efficacy, safety, and/or tolerability of a grass allergen-specific subcutaneous immunotherapy (SCIT) regimen in a subject having a grass allergy are provided. Methods comprising administering to a subject in need thereof a therapeutic composition comprising an interleukin-4 receptor (IL-4R) antagonist, such as an anti-IL-4R antibody or antigen-binding fragment thereof, are provided.
    Type: Grant
    Filed: August 5, 2020
    Date of Patent: November 22, 2022
    Assignees: REGENERON PHARMACEUTICALS, INC., SANOFI BIOTECHNOLOGY
    Inventors: Jennifer D. Hamilton, Meagan P. O'Brien, Allen Radin, Marcella Ruddy, Heribert Staudinger
  • METHODS OF TREATING ALLERGY USING ANTI-BET V 1 ANTIBODIES
    Publication number: 20220002394
    Abstract: The present disclosure provides methods for treating, preventing, or ameliorating one or more symptoms of birch allergy or allergic disease in a subject by administering to the subject an antibody or antigen-binding fragment thereof that binds Bet v 1, or a cocktail of antibodies or antigen-binding fragments thereof that bind Bet v 1.
    Type: Application
    Filed: June 30, 2021
    Publication date: January 6, 2022
    Inventors: Amanda Atanasio, Gary Herman, Meagan P. O'Brien, Jamie M. Orengo, Lorah Perlee
  • METHODS FOR TREATING ALLERGY AND ENHANCING ALLERGEN-SPECIFIC IMMUNOTHERAPY BY ADMINISTERING AN IL-4R ANTAGONIST
    Publication number: 20210038715
    Abstract: Methods for enhancing the efficacy, safety, and/or tolerability of a grass allergen-specific subcutaneous immunotherapy (SCIT) regimen in a subject having a grass allergy are provided. Methods comprising administering to a subject in need thereof a therapeutic composition comprising an interleukin-4 receptor (IL-4R) antagonist, such as an anti-IL-4R antibody or antigen-binding fragment thereof, are provided.
    Type: Application
    Filed: August 5, 2020
    Publication date: February 11, 2021
    Inventors: Jennifer D. HAMILTON, Meagan P. O'Brien, Allen Radin, Marcella Ruddy, Heribert Staudinger